Quantitative analysis of multiple sclerosis patients' preferences for drug treatment: a best-worst scaling study
about
Using a multidimensional unfolding approach to assess multiple sclerosis patient preferences for disease-modifying therapy: a pilot studyConjoint analysis to understand preferences of patients with multiple sclerosis for disease-modifying therapy attributes in Spain: a cross-sectional observational studyA discrete choice experiment to determine UK patient preference for attributes of disease modifying treatments in Multiple Sclerosis.A Systematic Review of Discrete-Choice Experiments and Conjoint Analysis Studies in People with Multiple Sclerosis.Comparison of preferences of healthcare professionals and MS patients for attributes of disease-modifying drugs: A best-worst scaling.Using Latent Class Analysis to Model Preference Heterogeneity in Health: A Systematic Review.
P2860
Quantitative analysis of multiple sclerosis patients' preferences for drug treatment: a best-worst scaling study
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 15 May 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Quantitative analysis of multi ...... nt: a best-worst scaling study
@en
Quantitative analysis of multi ...... t: a best-worst scaling study.
@nl
type
label
Quantitative analysis of multi ...... nt: a best-worst scaling study
@en
Quantitative analysis of multi ...... t: a best-worst scaling study.
@nl
prefLabel
Quantitative analysis of multi ...... nt: a best-worst scaling study
@en
Quantitative analysis of multi ...... t: a best-worst scaling study.
@nl
P2093
P2860
P356
P1476
Quantitative analysis of multi ...... nt: a best-worst scaling study
@en
P2093
Anthony Traboulsee
Carlo A Marra
Charity Evans
Kathy H Li
Larry D Lynd
Melanie Carter
Nicole Mittmann
P2860
P304
P356
10.1177/1756285616648060
P577
2016-05-15T00:00:00Z